This announcement is a separate document:
普蕊斯：北京国枫律师事务所关于普蕊斯（上海）医药科技开发股份有限公司2022年限制性股票激励计划首次授予部分第一个解除限售期解除限售条件成就的法律意见书
Prius: Beijing Guofeng Law Firm\'s Legal Opinion on Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.\'s 2022 Restricted Stock Incentive Plan Grants for the First Time Part of the First Sale Cancellation Period and the Achievements of Liftin
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.